Korean Market
FTC
Seoul Pharma
★

Seoul Pharma files first corporate group status disclosure as QCP Group affiliate... Major shareholder holds 59.41%, stable financial structure but persistent operating loss

 
PERI
Seoul Pharma
★

Seoul Pharma Q1 2026: Net Loss but Improved Cash Flow and Net Cash Position